@article{dc682884230844c1b502b7b1041d90ce,
title = "Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes",
keywords = "Alogliptin, dipeptidyl peptidase-4 inhibitors, empagliflozin, glucagon-like peptide-1 agonists, liraglutide, lixisenatide, saxagliptin, sitagliptin, sodium-glucose cotransporter 2 inhibitors, type 2 diabetes mellitus",
author = "Brian Tomlinson and Miao Hu and Yuzhen Zhang and Paul Chan and Liu, {Zhong Min}",
note = "Copyright: Copyright 2017 Elsevier B.V., All rights reserved.",
year = "2016",
month = nov,
day = "1",
doi = "10.1080/17425255.2016.1234608",
language = "English",
volume = "12",
pages = "1267--1271",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Informa Healthcare",
number = "11",
}
